Canature Health Technology (300272.SZ) subsidiary signs a letter of intent for cooperation with Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital.

Canature Health Technology (300272.SZ) announced that, in order to actively respond to the national policy direction to promote innovation and industrial development in the field of biopharmaceuticals, especially in accordance with the relevant regulations such as "Supporting Medical Institutions to Conduct Investigator-Initiated Cell Therapy Clinical Research," the company has decided for its subsidiary Shanghai Yuantian Biological Technology Co., Ltd. (hereinafter referred to as "Party B" or "Yuantian Biological") to sign a "Letter of Intent for Cooperation" with the Sichuan Academy of Medical SciencesSichuan Provincial People's Hospital (hereinafter referred to as "Party A"). During the cooperation period from 2026 to 2030, Party B will invest a total amount of not less than 80 million yuan in GCP research projects in collaboration with Party A in the fields of orthopedics, ophthalmology, and aging-related diseases, conducting multiple GCP and IIT research projects on stem cells and immune cell preparations. In terms of research cooperation, the two parties will strengthen strategic cooperation in the following areas: promoting early clinical research, Investigator-Initiated Clinical Research (IIT), drug development, and real-world research in various disease diagnosis and treatment fields. During the collaboration period, if Party B's innovative drugs at different stages of research and development are marketed, Party A may establish clinical medical research centers/branches, jointly enhancing the academic influence of both parties and benefiting patients. During the collaboration period, Party B pledges to invest a total amount of not less than 80 million yuan in GCP research projects in collaboration with Party A from 2026 to 2030, utilizing Party A's strong disciplines and Party B's professional research pipeline to conduct multiple GCP and IIT research projects in the fields of orthopedics, ophthalmology, and aging-related diseases.